Boehringer Ingelheim
GastroGard® Paste (Rx) (Omeprazole)
$41.49
First FDA-approved treatment for equine protozoal myeloencephalitis (EPM). Is indicated as an aid in reducing the clinical severity of Equine Protozoal Myeloencephalitis (EPM) caused by Sarcocystis neurona in horses; it is expected that approximately two horses out of three will respond favourably to treatment. Four 127 g syringes/box.
This product is not eligible for any discounts.
Boehringer Ingelheim
Merck Animal Health
Boehringer Ingelheim
Merial
Boehringer Ingelheim
American Regent®